FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Wilbur Franklin

Research Profile

Disorders

Chemicals & Drugs

Procedures

Concepts & Ideas

Activities & Behaviors

Smoking

Physiology

Anatomy

Sputum

Co-author Network

Publications

TOP 3
Andrew J Weickhardt; Dara L Aisner; Robert C Doebele; Wilbur A Franklin; Marileila Varella-Garcia; D Ross Camidge
Diagnostic assays for identification of anaplastic lymphoma kinase-positive non-small cell lung cancer.
Celine Mascaux; Daniel T Merrick; York E Miller; John D Minna; Leslie M Rozeboom; Anna E Barón; Paul A Bunn; Christopher Coldren; John I Eckelberger; William J Feser; Wilbur A Franklin; Robert L Keith; Timothy C Kennedy; Marina T Lewis; Fred R Hirsch
Endobronchial miRNAs as biomarkers in lung cancer chemoprevention.
Robert C Doebele; Wilbur A Franklin; Xian Lu; Delee A Maxson; Ana B Oton; Christopher Sumey; Marileila Varella-Garcia; Andrew J Weickhardt; Dara L Aisner; Anna E Barón; Paul A Bunn; D Ross Camidge
Oncogene status predicts patterns of metastatic spread in treatment-naive nonsmall cell lung cancer.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Wilbur Franklin (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2013: Andrew J Weickhardt; Dara L Aisner; Robert C Doebele; Wilbur A Franklin; Marileila Varella-Garcia; D Ross Camidge
Diagnostic assays for identification of anaplastic lymphoma kinase-positive non-small cell lung cancer.
Cancer 2013;119(8):1467-77.
2013: Celine Mascaux; Daniel T Merrick; York E Miller; John D Minna; Leslie M Rozeboom; Anna E Barón; Paul A Bunn; Christopher Coldren; John I Eckelberger; William J Feser; Wilbur A Franklin; Robert L Keith; Timothy C Kennedy; Marina T Lewis; Fred R Hirsch
Endobronchial miRNAs as biomarkers in lung cancer chemoprevention.
Cancer prevention research (Philadelphia, Pa.) 2013;6(2):100-8.
2012: Robert C Doebele; Wilbur A Franklin; Xian Lu; Delee A Maxson; Ana B Oton; Christopher Sumey; Marileila Varella-Garcia; Andrew J Weickhardt; Dara L Aisner; Anna E Barón; Paul A Bunn; D Ross Camidge
Oncogene status predicts patterns of metastatic spread in treatment-naive nonsmall cell lung cancer.
Cancer 2012;118(18):4502-11.
2012: Shuguang Leng; Maria A Picchi; Christine A Stidley; Holly J Wolf; Christin M Yingling; Malcolm V Brock; Tim Byers; Kieu Do; William J Feser; Wilbur A Franklin; James G Herman; Timothy C Kennedy; Anna E Baron; Stephen B Baylin; Steven A Belinsky
Defining a gene promoter methylation signature in sputum for lung cancer risk assessment.
Clinical cancer research : an official journal of the American Association for Cancer Research 2012;18(12):3387-95.
2012: Wilbur A Franklin; Dara L Aisner; Marileila Varella-Garcia
Prognostic patterns in the histopathology of pulmonary adenocarcinoma.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2012;30(13):1401-3.
2012: Robert C Doebele; Wilbur A Franklin; Lynn E Heasley; Kimi L Kondo; Tatiana G Kutateladze; Anh T Le; Derek J Linderman; Amanda B Pilling; Marileila Varella-Garcia; Andrew J Weickhardt; Dara L Aisner; D Ross Camidge
Mechanisms of resistance to crizotinib in patients with ALK gene rearranged non-small cell lung cancer.
Clinical cancer research : an official journal of the American Association for Cancer Research 2012;18(5):1472-82.
2011: Fred R Hirsch; Fairooz Kabbinavar; Renato Martins; Frank Richardson; Katherine Richardson; Jason Rusk; Fredrick M Schnell; David W Sternberg; Marileila Varella-Garcia; Bret Wacker; Paul A Bunn; D Ross Camidge; Rafal Dziadziuszko; Tim Eisen; Wilbur A Franklin; D Ross Camidge
A randomized, phase II, biomarker-selected study comparing erlotinib to erlotinib intercalated with chemotherapy in first-line therapy for advanced non-small-cell lung cancer.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2011;29(26):3567-73.
2011: Robert L Keith; Patrick J Blatchford; John Kittelson; John D Minna; Karen Kelly; Pierre P Massion; Wilbur A Franklin; Jenny Mao; David O Wilson; Daniel T Merrick; Fred R Hirsch; Timothy C Kennedy; Paul A Bunn; Mark W Geraci; York E Miller
Oral iloprost improves endobronchial dysplasia in former smokers.
Cancer prevention research (Philadelphia, Pa.) 2011;4(6):793-802.
2011: S M Jamshedur Rahman; Adriana L Gonzalez; Ming Li; Erin H Seeley; Lisa J Zimmerman; Xueqiong J Zhang; M Lisa Manier; Sandra J Olson; Ronak N Shah; Alison N Miller; Joe B Putnam; York E Miller; Wilbur A Franklin; William J Blot; David P Carbone; Yu Shyr; Richard M Caprioli; Pierre P Massion
Lung cancer diagnosis from proteomic analysis of preinvasive lesions.
Cancer research 2011;71(8):3009-17.
2011: Jennifer M Symonds; Angela M Ohm; Cristan J Carter; Lynn E Heasley; Theresa A Boyle; Wilbur A Franklin; Mary E Reyland
Protein kinase C δ is a downstream effector of oncogenic K-ras in lung tumors.
Cancer research 2011;71(6):2087-97.
2011: D Ross Camidge; Fred R Hirsch; Marileila Varella-Garcia; Wilbur A Franklin
Finding ALK-positive lung cancer: what are we really looking for?
Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer 2011;6(3):411-3.
2011: Yoshimichi Tanaka; Yoshito Terai; Akiko Tanabe; Hiroshi Sasaki; Tatsuharu Sekijima; Satoe Fujiwara; Yoshiki Yamashita; Masanori Kanemura; Masatsugu Ueda; Michio Sugita; Wilbur A Franklin; Masahide Ohmichi
Prognostic effect of epidermal growth factor receptor gene mutations and the aberrant phosphorylation of Akt and ERK in ovarian cancer.
Cancer biology & therapy 2011;11(1):50-7.
2010: D Ross Camidge; Scott A Kono; Antonella Flacco; Aik Choon Tan; Robert C Doebele; Qing Zhou; Lucio Crino; Wilbur A Franklin; Marileila Varella-Garcia
Optimizing the detection of lung cancer patients harboring anaplastic lymphoma kinase (ALK) gene rearrangements potentially suitable for ALK inhibitor treatment.
Clinical cancer research : an official journal of the American Association for Cancer Research 2010;16(22):5581-90.
2010: Roy S Herbst; Karen Kelly; Kari Chansky; Philip C Mack; Wilbur A Franklin; Fred R Hirsch; James N Atkins; Shaker R Dakhil; Kathy S Albain; Edward S Kim; Mary Redman; John J Crowley; David R Gandara
Phase II selection design trial of concurrent chemotherapy and cetuximab versus chemotherapy followed by cetuximab in advanced-stage non-small-cell lung cancer: Southwest Oncology Group study S0342.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2010;28(31):4747-54.
2010: Katherine M W Pisters; Eric Vallières; John J Crowley; Wilbur A Franklin; Paul A Bunn; Robert J Ginsberg; Joe B Putnam; Kari Chansky; David R Gandara
Surgery with or without preoperative paclitaxel and carboplatin in early-stage non-small-cell lung cancer: Southwest Oncology Group Trial S9900, an intergroup, randomized, phase III trial.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2010;28(11):1843-9.
2010: Marileila Varella-Garcia; Aline P Schulte; Holly J Wolf; William J Feser; Chan Zeng; Sarah Braudrick; Xiang Yin; Fred R Hirsch; Timothy C Kennedy; Robert L Keith; Anna E Barón; Steven A Belinsky; York E Miller; Tim Byers; Wilbur A Franklin
The detection of chromosomal aneusomy by fluorescence in situ hybridization in sputum predicts lung cancer incidence.
Cancer prevention research (Philadelphia, Pa.) 2010;3(4):447-53.
2010: Federico Cappuzzo; Giovanni Tallini; Giovanna Finocchiaro; R S Wilson; Claudia Ligorio; L Giordano; Luca Toschi; M Incarbone; R Cavina; L Terracciano; M Roncalli; M Alloisio; Marileila Varella-Garcia; Wilbur A Franklin; A Santoro
Insulin-like growth factor receptor 1 (IGF1R) expression and survival in surgically resected non-small-cell lung cancer (NSCLC) patients.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 2010;21(3):562-7.
2010: Wilbur A Franklin; Jerry Haney; Michio Sugita; Lynne Bemis; Antonio Jimeno; Wells A Messersmith
KRAS mutation: comparison of testing methods and tissue sampling techniques in colon cancer.
The Journal of molecular diagnostics : JMD 2010;12(1):43-50.
2009: Rom S Leidner; Pingfu Fu; Bradley Clifford; Ayad Hamdan; Cheng Jin; Rosana Eisenberg; Titus Boggon; Margaret Skokan; Wilbur A Franklin; Federico Cappuzzo; Fred R Hirsch; Marileila Varella-Garcia; Balazs Halmos
Genetic abnormalities of the EGFR pathway in African American Patients with non-small-cell lung cancer.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2009;27(33):5620-6.
2009: Aftab Ahmad; Shama Ahmad; Louise Glover; Stacy M Miller; John M Shannon; Xiaoling Guo; Wilbur A Franklin; James P Bridges; Jerome B Schaack; Sean P Colgan; Carl W White
Adenosine A2A receptor is a unique angiogenic target of HIF-2alpha in pulmonary endothelial cells.
Proceedings of the National Academy of Sciences of the United States of America 2009;106(26):10684-9.
2009: Karen Kelly; John Kittelson; Wilbur A Franklin; Timothy C Kennedy; Catherine E Klein; Robert L Keith; Edward C Dempsey; Marina Lewis; Mary K Jackson; Fred R Hirsch; Paul A Bunn; York E Miller
A randomized phase II chemoprevention trial of 13-CIS retinoic acid with or without alpha tocopherol or observation in subjects at high risk for lung cancer.
Cancer prevention research (Philadelphia, Pa.) 2009;2(5):440-9.
2009: Antonio Jimeno; Wells A Messersmith; Fred R Hirsch; Wilbur A Franklin; S Gail Eckhardt
KRAS mutations and susceptibility to cetuximab and panitumumab in colorectal cancer.
Cancer journal (Sudbury, Mass.) 2009;15(2):110-3.
2009: Marileila Varella-Garcia; Tetsuya Mitsudomi; Yashushi Yatabe; Takayuki Kosaka; Eiji Nakajima; Ana Carolina Xavier; Margaret Skokan; Chan Zeng; Wilbur A Franklin; Paul A Bunn; Fred R Hirsch
EGFR and HER2 genomic gain in recurrent non-small cell lung cancer after surgery: impact on outcome to treatment with gefitinib and association with EGFR and KRAS mutations in a Japanese cohort.
Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer 2009;4(3):318-25.
2009: Antonio Jimeno; Wells A Messersmith; Fred R Hirsch; Wilbur A Franklin; S Gail Eckhardt
KRAS mutations and sensitivity to epidermal growth factor receptor inhibitors in colorectal cancer: practical application of patient selection.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2009;27(7):1130-6.
2009: Pierre P Massion; Yong Zou; Hasmet Uner; Porntip Kiatsimkul; Holly J Wolf; Anna E Baron; Tim E Byers; Steinn Jonsson; Stephen Lam; Fred R Hirsch; York E Miller; Wilbur A Franklin; Marileila Varella-Garcia
Recurrent genomic gains in preinvasive lesions as a biomarker of risk for lung cancer.
PloS one 2009;4(6):e5611.
2008: Philip C Mack; Mary W Redman; Kari Chansky; Stephen K Williamson; Nichole C Farneth; Primo Lara; Wilbur A Franklin; Quynh-Thu Le; John J Crowley; David R Gandara
Lower osteopontin plasma levels are associated with superior outcomes in advanced non-small-cell lung cancer patients receiving platinum-based chemotherapy: SWOG Study S0003.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2008;26(29):4771-6.
2008: Paul J Hesketh; Kari Chansky; Antoinette J Wozniak; Fred R Hirsch; Anna Spreafico; James Moon; Philip C Mack; Benjamin T Marchello; Wilbur A Franklin; John J Crowley; David R Gandara
Southwest Oncology Group phase II trial (S0341) of erlotinib (OSI-774) in patients with advanced non-small cell lung cancer and a performance status of 2.
Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer 2008;3(9):1026-31.
2008: David H Garfield; Wilbur A Franklin
A comparison of survival and disease-specific survival in surgically resected, lymph node-positive bronchioloalveolar carcinoma versus nonsmall cell lung cancer: implications for adjuvant therapy.
Cancer 2008;113(5):1107-8; author reply 1108-9.
2008: Fred R Hirsch; Roy S Herbst; Christine Olsen; Kari Chansky; John Crowley; Karen Kelly; Wilbur A Franklin; Paul A Bunn; Marileila Varella-Garcia; David R Gandara
Increased EGFR gene copy number detected by fluorescent in situ hybridization predicts outcome in non-small-cell lung cancer patients treated with cetuximab and chemotherapy.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2008;26(20):3351-7.
2008: Fred R Hirsch; Rafal Dziadziuszko; Marileila Varella-Garcia; Wilbur A Franklin; David R Gandara; Paul A Bunn
First-generation epidermal growth factor receptor inhibitors in non-small cell lung cancer: clinical impact of the epidermal growth factor receptor fluorescence in situ hybridization assay.
Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer 2008;3(6 Suppl 2):S138-42.
2008: Jinru Shia; David S Klimstra; James R Nitzkorski; Philip S Low; Mithat Gonen; Ron Landmann; Martin R Weiser; Wilbur A Franklin; Franklyn G Prendergast; Linda Murphy; Laura H Tang; Larissa K Temple; Jose G Guillem; Douglas Wong; Philip B Paty
Immunohistochemical expression of folate receptor alpha in colorectal carcinoma: patterns and biological significance.
Human pathology 2008;39(4):498-505.
2008: Fred R Hirsch; Rafal Dziadziuszko; Nick Thatcher; Helen Mann; Claire Watkins; Dinah V Parums; Georgina Speake; Brian Holloway; Paul A Bunn; Wilbur A Franklin
Epidermal growth factor receptor immunohistochemistry: comparison of antibodies and cutoff points to predict benefit from gefitinib in a phase 3 placebo-controlled study in advanced nonsmall-cell lung cancer.
Cancer 2008;112(5):1114-21.
2008: Steinn Jonsson; Marileila Varella-Garcia; York E Miller; Holly J Wolf; Tim E Byers; Sarah Braudrick; Porntip Kiatsimkul; Marina Lewis; Timothy C Kennedy; Robert L Keith; Johannes Bjornsson; Annette McWilliams; Stephen Lam; Fred R Hirsch; Wilbur A Franklin
Chromosomal aneusomy in bronchial high-grade lesions is associated with invasive lung cancer.
American journal of respiratory and critical care medicine 2008;177(3):342-7.
2008: Tim E Byers; Holly J Wolf; Wilbur A Franklin; Sarah Braudrick; Daniel T Merrick; Kenneth R Shroyer; Fred R Hirsch; Chan Zeng; Anna E Barón; Paul A Bunn; York E Miller; Timothy C Kennedy
Sputum cytologic atypia predicts incident lung cancer: defining latency and histologic specificity.
Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology 2008;17(1):158-62.
2007: York E Miller; Patrick Blatchford; Dae Sung Hyun; Robert L Keith; Timothy C Kennedy; Holly Wolf; Tim E Byers; Paul A Bunn; Marina T Lewis; Wilbur A Franklin; Fred R Hirsch; John Kittelson
Bronchial epithelial Ki-67 index is related to histology, smoking, and gender, but not lung cancer or chronic obstructive pulmonary disease.
Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology 2007;16(11):2425-31.
2007: Marileila Varella-Garcia; Lin Chen; Roger L Powell; Fred R Hirsch; Timothy C Kennedy; Robert L Keith; York E Miller; John D Mitchell; Wilbur A Franklin
Spectral karyotyping detects chromosome damage in bronchial cells of smokers and patients with cancer.
American journal of respiratory and critical care medicine 2007;176(5):505-12.
2007: Lynne Bemis; William A Robinson; Robert McFarlane; Elizabeth Buyers; Karen Kelly; Marileila Varella-Garcia; John D Mitchell; Wilbur A Franklin
EGFR-mutant lung adenocarcinoma in a patient with Li-Fraumeni syndrome.
The lancet oncology 2007;8(6):559-60.
2007: Steven A Belinsky; Marcie J Grimes; E Casas; Christine A Stidley; Wilbur A Franklin; Therese J Bocklage; D H Johnson; J H Schiller
Predicting gene promoter methylation in non-small-cell lung cancer by evaluating sputum and serum.
British journal of cancer 2007;96(8):1278-83.
2007: Fred R Hirsch; Marileila Varella-Garcia; Federico Cappuzzo; Jason McCoy; Lynne Bemis; A C Xavier; Rafal Dziadziuszko; Paul H Gumerlock; Kari Chansky; Howard L West; Adi F Gazdar; Lucio Crino; David R Gandara; Wilbur A Franklin; Paul A Bunn
Combination of EGFR gene copy number and protein expression predicts outcome for advanced non-small-cell lung cancer patients treated with gefitinib.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 2007;18(4):752-60.
2007: Rafal Dziadziuszko; B Holm; B G Skov; Kell Osterlind; M V Sellers; Wilbur A Franklin; Paul A Bunn; Marileila Varella-Garcia; Fred R Hirsch
Epidermal growth factor receptor gene copy number and protein level are not associated with outcome of non-small-cell lung cancer patients treated with chemotherapy.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 2007;18(3):447-52.
2007: Wilbur A Franklin
RAGE in lung tumors.
American journal of respiratory and critical care medicine 2007;175(2):106-7.
2006: Nathan W Pearlman; Martin D McCarter; Matthew Frank; Cheryl Hurtubis; Ryan P Merkow; Wilbur A Franklin; Rene Gonzalez; Karl Lewis; J Brent Roaten; William A Robinson
Size of sentinel node metastases predicts other nodal disease and survival in malignant melanoma.
American journal of surgery 2006;192(6):878-81.
2006: Barbara Helfrich; David Raben; Marileila Varella-Garcia; Dan Gustafson; Daniel C Chan; Lynne Bemis; Chris Coldren; Anna E Barón; Chan Zeng; Wilbur A Franklin; Fred R Hirsch; Adi F Gazdar; John D Minna; Paul A Bunn
Antitumor activity of the epidermal growth factor receptor (EGFR) tyrosine kinase inhibitor gefitinib (ZD1839, Iressa) in non-small cell lung cancer cell lines correlates with gene copy number and EGFR mutations but not EGFR protein levels.
Clinical cancer research : an official journal of the American Association for Cancer Research 2006;12(23):7117-25.
2006: William D Travis; Kavita Garg; Wilbur A Franklin; Ignacio I Wistuba; Bradley Sabloff; Masayuki Noguchi; Ryutaro Kakinuma; Maureen F Zakowski; Michelle Ginsberg; Robert F Padera; Francine Jacobson; Bruce E Johnson; Fred Hirsch; Elizabeth Brambilla; Douglas B Flieder; Kim R Geisinger; Frederik B J M Thunnissen; Keith Kerr; David Yankelevitz; Teri J Franks; Jeffrey Galvin; Douglas W Henderson; Andrew G Nicholson; Philip S Hasleton; Victor L Roggli; Ming Tsao; Federico Cappuzzo; Madeline Vazquez
Bronchioloalveolar carcinoma and lung adenocarcinoma: the clinical importance and research relevance of the 2004 World Health Organization pathologic criteria.
Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer 2006;1(9 Suppl):S13-9.
2006: Primo Lara; Kari Chansky; Angela M Davies; Wilbur A Franklin; Paul H Gumerlock; Perry P Guaglianone; James N Atkins; Nichole Farneth; Philip C Mack; John J Crowley; David R Gandara
Bortezomib (PS-341) in relapsed or refractory extensive stage small cell lung cancer: a Southwest Oncology Group phase II trial (S0327).
Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer 2006;1(9):996-1001.
2006: Fred R Hirsch; Marileila Varella-Garcia; Paul A Bunn; Wilbur A Franklin; Rafal Dziadziuszko; Nick Thatcher; ALEX CHANG; Purvish Parikh; Jose R Pereira; tudor ciuleanu; Joachim von Pawel; Claire Watkins; Angela Flannery; Gillian Ellison; Emma Donald; Lucy Knight; Dinah Parums; Nick Botwood; Brian Holloway
Molecular predictors of outcome with gefitinib in a phase III placebo-controlled study in advanced non-small-cell lung cancer.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2006;24(31):5034-42.
2006: Christopher Coldren; Barbara Helfrich; Samir E Witta; Michio Sugita; Razvan Lapadat; Chan Zeng; Anna E Barón; Wilbur A Franklin; Fred R Hirsch; Mark W Geraci; Paul A Bunn
Baseline gene expression predicts sensitivity to gefitinib in non-small cell lung cancer cell lines.
Molecular cancer research : MCR 2006;4(8):521-8.
2006: Federico Cappuzzo; Luca Toschi; Giovanni Tallini; Giovanni Luca Ceresoli; Irene Domenichini; Stefania Bartolini; Giovanna Finocchiaro; Elisabetta Magrini; Giulio Metro; Alessandra Cancellieri; Rocco Trisolini; Lucio Crino; Paul A Bunn; A Santoro; Wilbur A Franklin; Marileila Varella-Garcia; Fred R Hirsch
Insulin-like growth factor receptor 1 (IGFR-1) is significantly associated with longer survival in non-small-cell lung cancer patients treated with gefitinib.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 2006;17(7):1120-7.
2006: Paul A Bunn; Rafal Dziadziuszko; Marileila Varella-Garcia; Wilbur A Franklin; Samir E Witta; Karen Kelly; Fred R Hirsch
Biological markers for non-small cell lung cancer patient selection for epidermal growth factor receptor tyrosine kinase inhibitor therapy.
Clinical cancer research : an official journal of the American Association for Cancer Research 2006;12(12):3652-6.
2006: Rafal Dziadziuszko; Samir E Witta; Federico Cappuzzo; Seongjin Park; Koji Tanaka; Peter V Danenberg; Anna E Barón; Lucio Crino; Wilbur A Franklin; Paul A Bunn; Marileila Varella-Garcia; Kathleen D Danenberg; Fred R Hirsch
Epidermal growth factor receptor messenger RNA expression, gene dosage, and gefitinib sensitivity in non-small cell lung cancer.
Clinical cancer research : an official journal of the American Association for Cancer Research 2006;12(10):3078-84.
2006: David H Garfield; Jacques L Cadranel; Marie Wislez; Wilbur A Franklin; Fred R Hirsch
The bronchioloalveolar carcinoma and peripheral adenocarcinoma spectrum of diseases.
Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer 2006;1(4):344-59.
2006: York E Miller; Kieu O Vu; Timothy C Kennedy; Fred R Hirsch; Thomas L Petty; Paul A Bunn; Robert L Keith; Wilbur A Franklin; Holly J Wolf; Sheila A Prindiville; Tim E Byers
Lack of association between sputum atypia and chronic obstructive pulmonary disease mortality.
Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer 2006;1(4):302-7.
2006: Howard L West; Wilbur A Franklin; Jason McCoy; Paul H Gumerlock; Ralph Vance; Derick H Lau; Kari Chansky; John J Crowley; David R Gandara
Gefitinib therapy in advanced bronchioloalveolar carcinoma: Southwest Oncology Group Study S0126.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2006;24(12):1807-13.
2006: Daniel T Merrick; John Kittelson; Ralph Winterhalder; Georgia Kotantoulas; Steen Ingeberg; Robert L Keith; Timothy C Kennedy; York E Miller; Wilbur A Franklin; Fred R Hirsch
Analysis of c-ErbB1/epidermal growth factor receptor and c-ErbB2/HER-2 expression in bronchial dysplasia: evaluation of potential targets for chemoprevention of lung cancer.
Clinical cancer research : an official journal of the American Association for Cancer Research 2006;12(7 Pt 1):2281-8.
2006: Steven A Belinsky; Kieu C Liechty; Frederick D Gentry; Holly J Wolf; Justin Rogers; Kieu O Vu; Jerry Haney; Timothy C Kennedy; Fred R Hirsch; York E Miller; Wilbur A Franklin; James G Herman; Stephen B Baylin; Paul A Bunn; Tim E Byers
Promoter hypermethylation of multiple genes in sputum precedes lung cancer incidence in a high-risk cohort.
Cancer research 2006;66(6):3338-44.
2005: S M Jamshedur Rahman; Yu Shyr; Pinar Yildiz; Adriana L Gonzalez; Huiming Li; Xueqiong Zhang; Pierre Chaurand; Kiyoshi Yanagisawa; Bonnie S Slovis; Robert F Miller; Mathew Ninan; York E Miller; Wilbur A Franklin; Richard M Caprioli; David P Carbone; Pierre P Massion
Proteomic patterns of preinvasive bronchial lesions.
American journal of respiratory and critical care medicine 2005;172(12):1556-62.
2005: Federico Cappuzzo; Luca Toschi; Irene Domenichini; Stefania Bartolini; Giovanni Luca Ceresoli; E Rossi; Vienna Ludovini; Alessandra Cancellieri; Elisabetta Magrini; Lynne Bemis; Wilbur A Franklin; Lucio Crino; Paul A Bunn; Fred R Hirsch; Marileila Varella-Garcia
HER3 genomic gain and sensitivity to gefitinib in advanced non-small-cell lung cancer patients.
British journal of cancer 2005;93(12):1334-40.
2005: Robert Stearman; Lori D Dwyer-Nield; Laura K Zerbe; Stacy A Blaine; Zeng Chan; Paul A Bunn; Gary L Johnson; Fred R Hirsch; Daniel T Merrick; Wilbur A Franklin; Anna E Baron; Robert L Keith; Raphael A Nemenoff; Alvin M Malkinson; Mark W Geraci
Analysis of orthologous gene expression between human pulmonary adenocarcinoma and a carcinogen-induced murine model.
The American journal of pathology 2005;167(6):1763-75.
2005: Fred R Hirsch; Marileila Varella-Garcia; Jason McCoy; Howard L West; Ana Carolina Xavier; Paul H Gumerlock; Paul A Bunn; Wilbur A Franklin; John Crowley; David R Gandara
Increased epidermal growth factor receptor gene copy number detected by fluorescence in situ hybridization associates with increased sensitivity to gefitinib in patients with bronchioloalveolar carcinoma subtypes: a Southwest Oncology Group Study.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2005;23(28):6838-45.
2005: Federico Cappuzzo; Marileila Varella-Garcia; Hisayuki Shigematsu; Irene Domenichini; Stefania Bartolini; Giovanni Luca Ceresoli; Elisa Rossi; Vienna Ludovini; Vanesa Gregorc; Luca Toschi; Wilbur A Franklin; Lucio Crino; Adi F Gazdar; Paul A Bunn; Fred R Hirsch
Increased HER2 gene copy number is associated with response to gefitinib therapy in epidermal growth factor receptor-positive non-small-cell lung cancer patients.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2005;23(22):5007-18.
2005: Timothy C Kennedy; Wilbur A Franklin; Sheila A Prindiville; Robert Cook; Edward C Dempsey; Robert L Keith; Fred R Hirsch; Thomas A Merrick; Kenneth R Shroyer; Thomas L Petty; Tim E Byers; Paul A Bunn; York E Miller
High prevalence of occult endobronchial malignancy in high risk patients with moderate sputum atypia.
Lung cancer (Amsterdam, Netherlands) 2005;49(2):187-91.
2005: Howard L West; John J Crowley; R B Vance; Wilbur A Franklin; Robert B Livingston; Shaker R Dakhil; Jeffrey K Giguere; Saul E Rivkin; M Kraut; Kari Chansky; David R Gandara
Advanced bronchioloalveolar carcinoma: a phase II trial of paclitaxel by 96-hour infusion (SWOG 9714): a Southwest Oncology Group study.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 2005;16(7):1076-80.
2005: William D Travis; Kavita Garg; Wilbur A Franklin; Ignacio I Wistuba; Bradley Sabloff; Masayuki Noguchi; Ryutaro Kakinuma; Maureen F Zakowski; Michelle Ginsberg; Robert F Padera; Francine Jacobson; Bruce E Johnson; Fred Hirsch; Elizabeth Brambilla; Douglas B Flieder; Kim R Geisinger; Frederik Thunnisen; Keith Kerr; David Yankelevitz; Teri J Franks; Jeffrey Galvin; Douglas W Henderson; Andrew G Nicholson; Philip S Hasleton; Victor L Roggli; Ming Tsao; Federico Cappuzzo; Madeline Vazquez
Evolving concepts in the pathology and computed tomography imaging of lung adenocarcinoma and bronchioloalveolar carcinoma.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2005;23(14):3279-87.
2005: Federico Cappuzzo; Fred R Hirsch; Elisa Rossi; Stefania Bartolini; Giovanni Luca Ceresoli; Lynne Bemis; Jerry Haney; Samir E Witta; Kathleen D Danenberg; Irene Domenichini; Vienna Ludovini; Elisabetta Magrini; Vanesa Gregorc; Claudio Doglioni; Angelo Sidoni; Maurizio Tonato; Wilbur A Franklin; Lucio Crino; Paul A Bunn; Marileila Varella-Garcia
Epidermal growth factor receptor gene and protein and gefitinib sensitivity in non-small-cell lung cancer.
Journal of the National Cancer Institute 2005;97(9):643-55.
2005: Daniel T Merrick; Jerry Haney; Sheila Petrunich; Michio Sugita; York E Miller; Robert L Keith; Timothy C Kennedy; Wilbur A Franklin
Overexpression of vascular endothelial growth factor and its receptors in bronchial dypslasia demonstrated by quantitative RT-PCR analysis.
Lung cancer (Amsterdam, Netherlands) 2005;48(1):31-45.
2005: Michiko Iwamoto; Edward J Hoffenberg; John M Carethers; Ryan Doctolero; Akihiro Tajima; Kentaro Sugano; Wilbur A Franklin; Dennis J Ahnen
Nuclear accumulation of beta-catenin occurs commonly in the epithelial cells of juvenile polyps.
Pediatric research 2005;57(1):4-9; discussion 1-3.
2004: Robert L Keith; York E Miller; Tyler M Hudish; Carlos E Girod; Sylk Sotto-Santiago; Wilbur A Franklin; Raphael A Nemenoff; Thomas H March; S Patrick Nana-Sinkam; Mark W Geraci
Pulmonary prostacyclin synthase overexpression chemoprevents tobacco smoke lung carcinogenesis in mice.
Cancer research 2004;64(16):5897-904.
2004: Thomas D Chanin; Daniel T Merrick; Wilbur A Franklin; Fred R Hirsch
Recent developments in biomarkers for the early detection of lung cancer: perspectives based on publications 2003 to present.
Current opinion in pulmonary medicine 2004;10(4):242-7.
2004: David R Gandara; Howard L West; Kari Chansky; Angela M Davies; Derick H Lau; John Crowley; Paul H Gumerlock; Fred R Hirsch; Wilbur A Franklin
Bronchioloalveolar carcinoma: a model for investigating the biology of epidermal growth factor receptor inhibition.
Clinical cancer research : an official journal of the American Association for Cancer Research 2004;10(12 Pt 2):4205s-4209s.
2004: Yago Nieto; Wilbur A Franklin; Roy B Jones; Scott I Berman; Julie Pellom; Anna E Barón; Elizabeth J Shpall
Prognostic significance of occult tumor cells in the apheresis products of patients with advanced breast cancer receiving high-dose chemotherapy and autologous hematopoietic progenitor cell support.
Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 2004;10(6):415-25.
2004: Timothy C Kennedy; Wilbur A Franklin; Sheila A Prindiville; Robert Cook; Edward C Dempsey; Robert L Keith; Fred R Hirsch; Thomas A Merrick; Kenneth R Shroyer; Thomas L Petty; Tim E Byers; Paul A Bunn; York E Miller
High prevalence of endobronchial malignancy in high-risk patients with moderate dysplasia in sputum.
Chest 2004;125(5 Suppl):109S.
2004: Wilbur A Franklin
Premalignant evolution of lung cancer: Gilles F Filley lecture.
Chest 2004;125(5 Suppl):90S-4S.
2004: Matthew Meyerson; Wilbur A Franklin; Michael J Kelley
Molecular classification and molecular genetics of human lung cancers.
Seminars in oncology 2004;31(1 Suppl 1):4-19.
2004: Marileila Varella-Garcia; John Kittelson; Aline P Schulte; Kieu O Vu; Holly J Wolf; Chan Zeng; Fred R Hirsch; Tim E Byers; Tim Kennedy; York E Miller; Robert L Keith; Wilbur A Franklin
Multi-target interphase fluorescence in situ hybridization assay increases sensitivity of sputum cytology as a predictor of lung cancer.
Cancer detection and prevention 2004;28(4):244-51.
2003: Fred R Hirsch; Marileila Varella-Garcia; Paul A Bunn; Michael V Di Maria; Robert Veve; Roy M Bremmes; Anna E Barón; Chan Zeng; Wilbur A Franklin
Epidermal growth factor receptor in non-small-cell lung carcinomas: correlation between gene copy number and protein expression and impact on prognosis.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2003;21(20):3798-807.
2003: Sheila A Prindiville; Tim E Byers; Fred R Hirsch; Wilbur A Franklin; York E Miller; Kieu O Vu; Holly J Wolf; Anna E Barón; Kenneth R Shroyer; Chan Zeng; Timothy C Kennedy; Paul A Bunn
Sputum cytological atypia as a predictor of incident lung cancer in a cohort of heavy smokers with airflow obstruction.
Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology 2003;12(10):987-93.
2003: York E Miller; Lori D Dwyer-Nield; Robert L Keith; Mysan Le; Wilbur A Franklin; Alvin M Malkinson
Induction of a high incidence of lung tumors in C57BL/6 mice with multiple ethyl carbamate injections.
Cancer letters 2003;198(2):139-44.
2003: Wilbur A Franklin; David P Carbone
Molecular staging and pharmacogenomics. Clinical implications: from lab to patients and back.
Lung cancer (Amsterdam, Netherlands) 2003;41 Suppl 1():S147-54.
2003: Fred R Hirsch; Giorgio V Scagliotti; Corey J Langer; Marileila Varella-Garcia; Wilbur A Franklin
Epidermal growth factor family of receptors in preneoplasia and lung cancer: perspectives for targeted therapies.
Lung cancer (Amsterdam, Netherlands) 2003;41 Suppl 1():S29-42.
2003: Maura Santos Romeo; Irina A Sokolova; Larry E Morrison; Chan Zeng; Anna E Barón; Fred R Hirsch; York E Miller; Wilbur A Franklin; Marileila Varella-Garcia
Chromosomal abnormalities in non-small cell lung carcinomas and in bronchial epithelia of high-risk smokers detected by multi-target interphase fluorescence in situ hybridization.
The Journal of molecular diagnostics : JMD 2003;5(2):103-12.
2002: Robert A Winn; Roy M Bremnes; Lynne Bemis; Wilbur A Franklin; York E Miller; Carlyne D Cool; Lynn E Heasley
gamma-Catenin expression is reduced or absent in a subset of human lung cancers and re-expression inhibits transformed cell growth.
Oncogene 2002;21(49):7497-506.
2002: Fred R Hirsch; Paul A Bunn; Ethan Dmitrovsky; John Field; Wilbur A Franklin; R E Greenberg; H H Hansen; C I Henschke; James R Rigas; Robert Smith; P Toennesen; J L Mulshine
IV international conference on prevention and early detection of lung cancer, Reykjavik, Iceland, August 9-12, 2001.
Lung cancer (Amsterdam, Netherlands) 2002;37(3):325-44.
2002: Michio Sugita; Mark W Geraci; Bifeng Gao; Roger L Powell; Fred R Hirsch; Gary L Johnson; Razvan Lapadat; Edward Gabrielson; Roy M Bremnes; Paul A Bunn; Wilbur A Franklin
Combined use of oligonucleotide and tissue microarrays identifies cancer/testis antigens as biomarkers in lung carcinoma.
Cancer research 2002;62(14):3971-9.
2002: Fred R Hirsch; Daniel T Merrick; Wilbur A Franklin
Role of biomarkers for early detection of lung cancer and chemoprevention.
The European respiratory journal : official journal of the European Society for Clinical Respiratory Physiology 2002;19(6):1151-8.
2002: Fred R Hirsch; Wilbur A Franklin; Paul A Bunn
Expression of target molecules in lung cancer: challenge for a new treatment paradigm.
Seminars in oncology 2002;29(3 Suppl 9):2-8.
2002: Fred R Hirsch; Wilbur A Franklin; Paul A Bunn
What is the role of HER-2/neu and trastuzumab (Herceptin) in lung cancer?
Lung cancer (Amsterdam, Netherlands) 2002;36(3):263-4.
2002: Roy M Bremnes; Robert Veve; Edward Gabrielson; Fred R Hirsch; Anna Baron; Lynne Bemis; Robert M Gemmill; Harry A Drabkin; Wilbur A Franklin
High-throughput tissue microarray analysis used to evaluate biology and prognostic significance of the E-cadherin pathway in non-small-cell lung cancer.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2002;20(10):2417-28.
2002: Fred R Hirsch; Marileila Varella-Garcia; Wilbur A Franklin; Robert Veve; L Chen; Barbara Helfrich; Chan Zeng; Anna Baron; Paul A Bunn
Evaluation of HER-2/neu gene amplification and protein expression in non-small cell lung carcinomas.
British journal of cancer 2002;86(9):1449-56.
2002: Fred R Hirsch; Barbara Helfrich; Wilbur A Franklin; Marileila Varella-Garcia; Daniel C Chan; Paul A Bunn
Preclinical studies of gemcitabine and trastuzumab in breast and lung cancer cell lines.
Clinical breast cancer 2002;3 Suppl 1():12-6.
2002: Roy M Bremnes; Robert Veve; Fred R Hirsch; Wilbur A Franklin
The E-cadherin cell-cell adhesion complex and lung cancer invasion, metastasis, and prognosis.
Lung cancer (Amsterdam, Netherlands) 2002;36(2):115-24.
2002: Fred R Hirsch; Wilbur A Franklin; Robert Veve; Marileila Varella-Garcia; Paul A Bunn
HER2/neu expression in malignant lung tumors.
Seminars in oncology 2002;29(1 Suppl 4):51-8.
2002: Wilbur A Franklin; Robert Veve; Fred R Hirsch; Barbara Helfrich; Paul A Bunn
Epidermal growth factor receptor family in lung cancer and premalignancy.
Seminars in oncology 2002;29(1 Suppl 4):3-14.
2002: Patrick P Koty; Haifan Zhang; Wilbur A Franklin; Samuel A Yousem; Rodney J Landreneau; Mark L Levitt
In vivo expression of p53 and Bcl-2 and their role in programmed cell death in premalignant and malignant lung lesions.
Lung cancer (Amsterdam, Netherlands) 2002;35(2):155-63.
2001: Paul A Bunn; Barbara Helfrich; A F Soriano; Wilbur A Franklin; Marileila Varella-Garcia; Fred R Hirsch; Anna Baron; Chan Zeng; Daniel C Chan
Expression of Her-2/neu in human lung cancer cell lines by immunohistochemistry and fluorescence in situ hybridization and its relationship to in vitro cytotoxicity by trastuzumab and chemotherapeutic agents.
Clinical cancer research : an official journal of the American Association for Cancer Research 2001;7(10):3239-50.
2001: Fred R Hirsch; Sheila A Prindiville; York E Miller; Wilbur A Franklin; Edward C Dempsey; J R Murphy; Paul A Bunn; Timothy C Kennedy
Fluorescence versus white-light bronchoscopy for detection of preneoplastic lesions: a randomized study.
Journal of the National Cancer Institute 2001;93(18):1385-91.
2001: Michio Sugita; Jerry Haney; Robert M Gemmill; Wilbur A Franklin
One-step duplex reverse transcription-polymerase chain reaction for quantitative assessment of RNA degradation.
Analytical biochemistry 2001;295(1):113-6.
2001: M Berezuk; J West; Marileila Varella-Garcia; Wilbur A Franklin
Adjusting interphase FISH results in epithelial tissue sections to whole cell complement.
Analytical and quantitative cytology and histology / the International Academy of Cytology [and] American Society of Cytology 2001;23(2):93-100.
2001: Fred R Hirsch; Wilbur A Franklin; A F Gazdar; Paul A Bunn
Early detection of lung cancer: clinical perspectives of recent advances in biology and radiology.
Clinical cancer research : an official journal of the American Association for Cancer Research 2001;7(1):5-22.
2000: M Iwamoto; Dennis J Ahnen; Wilbur A Franklin; TH Maltzman
Expression of beta-catenin and full-length APC protein in normal and neoplastic colonic tissues.
Carcinogenesis 2000;21(11):1935-40.
2000: JK Stephens; Gregory T Everson; C L Elliott; Igal Kam; Michael Wachs; Jerry Haney; Stephen T Bartlett; Wilbur A Franklin
Fatal transfer of malignant melanoma from multiorgan donor to four allograft recipients.
Transplantation 2000;70(1):232-6.
2000: Robert L Keith; York E Miller; Robert M Gemmill; Harry A Drabkin; Edward C Dempsey; Timothy C Kennedy; Sheila A Prindiville; Wilbur A Franklin
Angiogenic squamous dysplasia in bronchi of individuals at high risk for lung cancer.
Clinical cancer research : an official journal of the American Association for Cancer Research 2000;6(5):1616-25.
2000: Wilbur A Franklin
Diagnosis of lung cancer: pathology of invasive and preinvasive neoplasia.
Chest 2000;117(4 Suppl 1):80S-89S.
1999: Andrea J Cohen; Wilbur A Franklin; Catherine Magill; J Sorenson; York E Miller
Low neutral endopeptidase levels in bronchoalveolar lavage fluid of lung cancer patients.
American journal of respiratory and critical care medicine 1999;159(3):907-10.
1998: Marileila Varella-Garcia; Robert M Gemmill; S H Rabenhorst; A Lotto; Harry A Drabkin; P A Archer; Wilbur A Franklin
Chromosomal duplication accompanies allelic loss in non-small cell lung carcinoma.
Cancer research 1998;58(20):4701-7.
1998: David Siegel; Wilbur A Franklin; David Ross
Immunohistochemical detection of NAD(P)H:quinone oxidoreductase in human lung and lung tumors.
Clinical cancer research : an official journal of the American Association for Cancer Research 1998;4(9):2065-70.
1998: Haifan Zhang; Samuel A Yousem; Wilbur A Franklin; Elaine Elder; Rodney J Landreneau; Peter F Ferson; Robert Keenan; Theresa L Whiteside; Mark L Levitt
Differentiation and programmed cell death-related intermediate biomarkers for the development of non-small cell lung cancer: a pilot study.
Human pathology 1998;29(9):965-71.
1997: Wilbur A Franklin; A F Gazdar; Jerry Haney; I I Wistuba; Francisco G La Rosa; Tim Kennedy; D M Ritchey; York E Miller
Widely dispersed p53 mutation in respiratory epithelium. A novel mechanism for field carcinogenesis.
The Journal of clinical investigation 1997;100(8):2133-7.
1997: Andrea J Cohen; Randal A Skidgel; LB Gilman; J K Black; Paul A Bunn; Barbara Helfrich; Wilbur A Franklin; York E Miller
Carboxypeptidase M. Variable expression in normal human lung and inactivation in lung cancer.
Chest 1997;111(6 Suppl):149S.
1997: D M Sorensen; T M Lewark; Jerry Haney; Arlen D Meyers; GE Krause; Wilbur A Franklin
Absence of p53 mutations in squamous carcinomas of the tongue in nonsmoking and nondrinking patients younger than 40 years.
Archives of otolaryngology--head & neck surgery 1997;123(5):503-6.
1997: S Todd; Wilbur A Franklin; Marileila Varella-Garcia; Tim Kennedy; C E Hilliker; L Hahner; M Anderson; Jonathan S Wiest; Harry A Drabkin; Robert M Gemmill
Homozygous deletions of human chromosome 3p in lung tumors.
Cancer research 1997;57(7):1344-52.
1997: Jonathan S Wiest; Wilbur A Franklin; Harry A Drabkin; Robert M Gemmill; David Sidransky; M W Anderson
Genetic markers for early detection of lung cancer and outcome measures for response to chemoprevention.
Journal of cellular biochemistry. Supplement 1997;28-29():64-73.
1997: D L Harland; William A Robinson; Wilbur A Franklin
Deletion of the p53 gene in a patient with aggressive burn scar carcinoma.
The Journal of trauma 1997;42(1):104-7.
1997: Jonathan S Wiest; Wilbur A Franklin; J T Otstot; K Forbey; Marileila Varella-Garcia; K Rao; Harry A Drabkin; Robert M Gemmill; S Ahrent; David Sidransky; G Saccomanno; J W Fountain; Marshall W Anderson
Identification of a novel region of homozygous deletion on chromosome 9p in squamous cell carcinoma of the lung: the location of a putative tumor suppressor gene.
Cancer research 1997;57(1):1-6.
1996: T C Kennedy; S P Proudfoot; Wilbur A Franklin; T A Merrick; G Saccomanno; M E Corkill; D L Mumma; K E Sirgi; Y E Miller; P G Archer; A Prochazka
Cytopathological analysis of sputum in patients with airflow obstruction and significant smoking histories.
Cancer research 1996;56(20):4673-8.
1996: Pablo J Cagnoni; Roy B Jones; Scott I Bearman; M Ross; LS Hami; Wilbur A Franklin; R Capizzi; P S Schein; Elizabeth J Shpall
Use of amifostine in bone marrow purging.
Seminars in oncology 1996;23(4 Suppl 8):44-8.
1996: M F Spafford; J Koeppe; Z Pan; P G Archer; Arlen D Meyers; Wilbur A Franklin
Correlation of tumor markers p53, bcl-2, CD34, CD44H, CD44v6, and Ki-67 with survival and metastasis in laryngeal squamous cell carcinoma.
Archives of otolaryngology--head & neck surgery 1996;122(6):627-32.
1996: Wilbur A Franklin; S Todd; Robert M Gemmill; Harry A Drabkin; R Cook; J Sorenson; J Folkvord; J Haney; R Low; T Parks; S Proudfoot; Tim Kennedy; York E Miller
Correlative assessment of morphologic, immunophenotypic, and genetic changes in bronchial epithelium of tobacco smokers.
Chest 1996;109(3 Suppl):26S.
1996: Andrea J Cohen; L B Gilman; M Moore; Wilbur A Franklin; York E Miller
Inactivation of neutral endopeptidase in lung cancer.
Chest 1996;109(3 Suppl):12S-13S.
1996: Wilbur A Franklin; Elizabeth J Shpall; P Archer; C S Johnston; S Garza-Williams; LS Hami; Mitchell A Bitter; R C Bast; Roy B Jones
Immunocytochemical detection of breast cancer cells in marrow and peripheral blood of patients undergoing high dose chemotherapy with autologous stem cell support.
Breast cancer research and treatment 1996;41(1):1-13.
1994: Mitchell A Bitter; D Fiorito; M E Corkill; William E Huffer; S M Stemmer; Elizabeth J Shpall; P G Archer; Wilbur A Franklin
Bone marrow involvement by lobular carcinoma of the breast cannot be identified reliably by routine histological examination alone.
Human pathology 1994;25(8):781-8.
1994: Elizabeth J Shpall; S M Stemmer; LS Hami; Wilbur A Franklin; L Shaw; H S Bonner; Scott I Bearman; W P Peters; R C Bast; W McCulloch
Amifostine (WR-2721) shortens the engraftment period of 4-hydroperoxycyclophosphamide-purged bone marrow in breast cancer patients receiving high-dose chemotherapy with autologous bone marrow support.
Blood 1994;83(11):3132-7.
1994: Elizabeth J Shpall; Roy B Jones; Scott I Bearman; M H Purdy; Wilbur A Franklin; S Heimfeld; R J Berenson
Transplantation of CD34+ hematopoietic progenitor cells.
Journal of hematotherapy 1994;3(2):145-7.
1994: Elizabeth J Shpall; Roy B Jones; Scott I Bearman; Wilbur A Franklin; P G Archer; Tyler J Curiel; Mitchell A Bitter; H N Claman; S M Stemmer; M Purdy
Transplantation of enriched CD34-positive autologous marrow into breast cancer patients following high-dose chemotherapy: influence of CD34-positive peripheral-blood progenitors and growth factors on engraftment.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1994;12(1):28-36.